278
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Appropriateness of Empirical Antibiotic Therapy in Hospitalized Patients with Bacterial Infection: A Retrospective Cohort Study

, , ORCID Icon, , , , , , , , , , & show all
Pages 4555-4568 | Received 28 Jan 2023, Accepted 22 Jun 2023, Published online: 12 Jul 2023

References

  • Raman G, Avendano E, Berger S, Menon V. Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis. BMC Infect Dis. 2015;15(1):395. doi:10.1186/s12879-015-1123-5
  • Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother. 2010;54(11):4851–4863. doi:10.1128/AAC.00627-10
  • Campion M, Scully G. Antibiotic use in the intensive care unit: optimization and De-Escalation. J Intensive Care Med. 2018;33(12):647–655. doi:10.1177/0885066618762747
  • Gradel KO, Jensen US, Schonheyder HC, et al. Impact of appropriate empirical antibiotic treatment on recurrence and mortality in patients with bacteraemia: a population-based cohort study. BMC Infect Dis. 2017;17(1):122. doi:10.1186/s12879-017-2233-z
  • Kadri SS, Lai YL, Warner S, et al. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. Lancet Infect Dis. 2021;21(2):241–251. doi:10.1016/S1473-3099(20)30477-1
  • Rhee C, Kadri SS, Dekker JP, et al. Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open. 2020;3(4):e202899. doi:10.1001/jamanetworkopen.2020.2899
  • Babich T, Zusman O, Elbaz M, et al. Empirical antibiotic treatment does not improve outcomes in catheter-associated urinary tract infection: prospective cohort study. Clin Infect Dis. 2017;65(11):1799–1805. doi:10.1093/cid/cix680
  • Kristel Marquet AL, Bergs J, Vleugels A, Claes N. Incidence and outcome of inappropriate in-hospital empiric antibiotics for severe infection: a systematic review and meta-analysis. Crit Care. 2015;19:1–2.
  • Timsit JF, Bassetti M, Cremer O, et al. Rationalizing antimicrobial therapy in the ICU: a narrative review. Intensive Care Med. 2019;45(2):172–189. doi:10.1007/s00134-019-05520-5
  • Cunha CB, Opal SM. Antibiotic stewardship: strategies to minimize antibiotic resistance while maximizing antibiotic effectiveness. Med Clin North Am. 2018;102(5):831–843. doi:10.1016/j.mcna.2018.04.006
  • Strich JR, Heil EL, Masur H. Considerations for empiric antimicrobial therapy in sepsis and septic shock in an era of antimicrobial resistance. J Infect Dis. 2020;222(Suppl 2):S119–S131. doi:10.1093/infdis/jiaa221
  • Zhao H, Wei L, Li H, et al. Appropriateness of antibiotic prescriptions in ambulatory care in China: a nationwide descriptive database study. Lancet Infect Dis. 2021;21(6):847–857. doi:10.1016/S1473-3099(20)30596-X
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
  • Spooner KK, Salemi JL, Salihu HM, Zoorob RJ. Discharge against medical advice in the United States, 2002–2011. Mayo Clin Proc. 2017;92(4):525–535. doi:10.1016/j.mayocp.2016.12.022
  • Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
  • Jane D, Siegel ER, Jackson M, Chiarello L. Management of multidrug-resistant organisms in healthcare settings, 2006. Am J Infect Control. 2007;35(10):S165–S193.
  • Micek ST, Welch EC, Khan J, et al. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis. Antimicrob Agents Chemother. 2010;54(5):1742–1748. doi:10.1128/AAC.01365-09
  • Platteel TN, Leverstein-van Hall MA, Cohen Stuart JW, et al. Predicting carriage with extended-spectrum beta-lactamase-producing bacteria at hospital admission: a cross-sectional study. Clin Microbiol Infect. 2015;21(2):141–146. doi:10.1016/j.cmi.2014.09.014
  • Huang X, Deng ZD, Ni YX, et al. Chinese experts’ consensus on prevention and control of multidrug resistance organism healthcare-associated infection. Chin J Infect Contr. 2015;14(01):1–9.
  • Kariv G, Paul M, Shani V, Muchtar E, Leibovici L. Benchmarking inappropriate empirical antibiotic treatment. Clin Microbiol Infect. 2013;19(7):629–633. doi:10.1111/j.1469-0691.2012.03965.x
  • Braykov NP, Morgan DJ, Schweizer ML, et al. Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study. Lancet Infect Dis. 2014;14(12):1220–1227. doi:10.1016/S1473-3099(14)70952-1
  • Mettler J, Simcock M, Sendi P, et al. Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: a prospective observational study. BMC Infect Dis. 2007;7:21. doi:10.1186/1471-2334-7-21
  • Carrara E, Pfeffer I, Zusman O, Leibovici L, Paul M. Determinants of inappropriate empirical antibiotic treatment: systematic review and meta-analysis. Int J Antimicrob Agents. 2018;51(4):548–553. doi:10.1016/j.ijantimicag.2017.12.013
  • Zilberberg MD, Shorr AF, Micek ST, Vazquez-Guillamet C, Kollef MH. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study. Crit Care. 2014;18(6):596. doi:10.1186/s13054-014-0596-8
  • World Health Organization. Global Antimicrobial Resistance Surveillance System (GLASS) Report: Early Implementation 2020. Geneva: World Health Organization; 2020.
  • Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance. Clin Microbiol Infect. 2016;22(5):416–422. doi:10.1016/j.cmi.2015.12.002
  • National Health and Family Planning Commission of the People’s Republic of China. National action plan to contain antimicrobial resistance (2016–2020); 2016. Available from: http://en.nhc.gov.cn/2016-08/26/c_70276.htm. Accessed February 27, 2022.
  • National Health and Family Planning Commission of the People’s Republic of China. Notice on continuous management of clinical application of antibiotics; 2020. Available from: http://www.gov.cn/zhengce/zhengceku/2020-07/24/content_5529693.htm. Accessed February 27, 2022.
  • China Antimicrobial Surveillance Network (CHINET). China antimicrobial surveillance network annual report (2021); 2021. Available from: http://www.chinets.com/Document. Accessed September 23, 2021.
  • Perez KK, Olsen RJ, Musick WL, et al. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. J Infect. 2014;69(3):216–225. doi:10.1016/j.jinf.2014.05.005
  • Wiener-Well Y, Hadeedi M, Schwartz Y, Yinnon AM, Munter G. Prospective audit of empirical antibiotic therapy for septic patients. Isr Med Assoc J. 2020;22(6):378–383.
  • Aryee A, Rockenschaub P, Gill MJ, Hayward A, Shallcross L. The relationship between clinical outcomes and empirical antibiotic therapy in patients with community-onset Gram-negative bloodstream infections: a cohort study from a large teaching hospital. Epidemiol Infect. 2020;148:e225. doi:10.1017/S0950268820002083
  • Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis*. Crit Care Med. 2006;34(1):15–21. doi:10.1097/01.CCM.0000194535.82812.BA
  • Schuttevaer R, Alsma J, Brink A, et al. Appropriate empirical antibiotic therapy and mortality: conflicting data explained by residual confounding. PLoS One. 2019;14(11):e0225478. doi:10.1371/journal.pone.0225478
  • Davey PG, Marwick C. Appropriate vs. inappropriate antimicrobial therapy. Clin Microbiol Infect. 2008;14:15–21. doi:10.1111/j.1469-0691.2008.01959.x
  • Chen HC, Lin WL, Lin CC, et al. Outcome of inadequate empirical antibiotic therapy in emergency department patients with community-onset bloodstream infections. J Antimicrob Chemother. 2013;68(4):947–953. doi:10.1093/jac/dks475
  • Kuti EL, Patel AA, Coleman CI. Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis. J Crit Care. 2008;23(1):91–100. doi:10.1016/j.jcrc.2007.08.007
  • Paul M, Kariv G, Goldberg E, et al. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2010;65(12):2658–2665. doi:10.1093/jac/dkq373
  • Naucler P, Huttner A, van Werkhoven CH, et al. Impact of time to antibiotic therapy on clinical outcome in patients with bacterial infections in the emergency department: implications for antimicrobial stewardship. Clin Microbiol Infect. 2021;27(2):175–181. doi:10.1016/j.cmi.2020.02.032
  • Buckman SA, Turnbull IR, Mazuski JE. Empiric antibiotics for sepsis. Surg Infect. 2018;19(2):147–154. doi:10.1089/sur.2017.282
  • van der Velden LB, Tromp M, Bleeker-Rovers CP, et al. Non-adherence to antimicrobial treatment guidelines results in more broad-spectrum but not more appropriate therapy. Eur J Clin Microbiol Infect Dis. 2012;31(7):1561–1568. doi:10.1007/s10096-011-1478-5
  • Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42 Suppl 2:S82–S89. doi:10.1086/499406
  • Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–377. doi:10.1007/s00134-017-4683-6